Nevro Corp has been recognized for its differentiated high-frequency SCS offerings and solid sales base. However, the company has faced challenges in recent years, struggling with market share and ...

Nevro Corp (NYSE:NVRO) is set to release its Q4 2024 earnings on Mar 4, 2025. The consensus estimate for Q4 2024 revenue is $102.54 million, and the earnings are expected to come in at -$0.79 per ...

Nevro Corp ( (NVRO)) has released its Q3 earnings. Here is a breakdown of the information Nevro Corp presented to its investors. Nevro Corp., based in Redwood City, California, is a global medical ...

Nevro Corp. shares have significantly underperformed, selling 57% lower than in 2021. The company's top-line momentum continues, but it faces economic challenges and lacks value creation for ...

Alger Weatherbie Specialized Growth Fund highlighted stocks like Nevro Corp. (NYSE:NVRO), in the first quarter 2024 investor letter. Nevro Corp. (NYSE:NVRO) is a medical device company.

REDWOOD CITY, Calif., Oct. 10, 2022 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...

On December 1, 2024, Nevro Corp. became aware of a security incident on its network. Upon detection, Nevro launched an investigation with the assistance of third-party cyber security experts to ...

On April 3, 2025, Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the company’s possession was subject to unauthorized access.

Nevro Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Audra, and I will be your ...

Nevro Corp (NVRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on December 1. Analyst William Plovanic from Canaccord Genuity remains neutral on the ...